C29H39NO4
Neat
465.6
-20°C
Room Temperature
18, 19-Dehydrobuprenorphine; 155203-05-7; 18, 19-Dehydrobuprenorphine (1.0mg/ml in Acetonitrile); ETHENOBUPRENORPHINE; BB3EB8AQ3P; SCHEMBL9961424; DTXSID701103363; HS-599; FC179884; BUPRENORPHINE IMPURITY J [EP IMPURITY]; BUPRENORPHINE HYDROCHLORIDE IMPURITY J [EP IMPURITY]; (1R, 2S, 6R, 14R, 15R, 19R)-5-(cyclopropylmethyl)-19-[(1S)-1-hydroxy-1, 2, 2-trimethyl-propyl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12, 8.01, 6.02, 14.012, 20]icosa-8(20), 9, 11, 16-tetraen-11-ol; (2S)-2-[17-(Cyclopropylmethyl)-4, 5a-epoxy-3-hydroxy-6-methoxy-6a, 14-etheno-14a-morphinan-7a-yl]-3, 3-dimethylbutan-2-ol; (alphaS, 5alpha, 7alpha)-17-(Cyclopropylmethyl)-alpha-(1, 1-dimethylethyl)-4, 5-epoxy-3-hydroxy-6-methoxy-alpha-methyl-6, 14-ethenomorphinan-7-methanol; (S)-2-(17-(CYCLOPROPYLMETHYL)-4, 5.ALPHA.-EPOXY-3-HYDROXY-6-METHOXY-6.ALPHA., 14-ETHENOMORPHINAN-7.ALPHA.-YL)-3, 3-DIMETHYLBUTAN-2-OL; [5?, 7?(S)]-17-(Cyclopropylmethyl)-?-(1, 1-dimethylethyl)-4, 5-epoxy-3-hydroxy-6-methoxy-?-methyl-6, 14-ethenomorphinan-7-methanol;; 6, 14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1, 1-dimethylethyl)-4, 5-epoxy-3-hydroxy-6-methoxy-alpha-methyl-, [5alpha and 7alpha(S)]-
(1R, 2S, 6R, 14R, 15R, 19R)-5-(cyclopropylmethyl)-19-[(2S)-2-hydroxy-3, 3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12, 8.01, 6.02, 14.012, 20]icosa-8(20), 9, 11 and 16-tetraen-11-ol
InChI=1S/C29H39NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-11,17,20-21,24,31-32H,6-7,12-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29-/m1/s1